Andrew Pati Ah Young-Chapon

Andrew Pati Ah Young-Chapon, Ph.D. has a diverse work experience in the field of immunology and biomedical research. Andrew Pati is currently serving as the Associate Director - Immunology (Myeloid Biology) at Dren Bio, Inc., where they are responsible for leading immunology research activities. Prior to this role, they worked as a Senior Scientist and Scientist 2 at Dren Bio, where they championed multiple targets and played a key role in driving pre-clinical efforts to support the company's series A financing.

Before joining Dren Bio, Andrew worked at Gilead Sciences as a Research Scientist, focusing on inflammation and rheumatoid arthritis. At Genentech, they held the position of Postdoctoral Research Fellow, investigating the role of neutrophil serine proteases in biology and human diseases within the Departments of Early Discovery Biochemistry and Immunology.

Andrew's academic background includes their tenure as a Graduate Student Researcher at UCLA David Geffen School of Medicine, where they conducted research as part of their Ph.D. studies. Prior to that, they worked as an IMSD Research Scholar at the University of New Mexico and as an Amgen Research Scholar at the University of California - Berkeley.

Overall, Andrew Pati Ah Young-Chapon, Ph.D. has demonstrated expertise in immunology, structural biology, and protein biochemistry throughout their various roles in academia and industry.

Andrew Pati Ah Young-Chapon, Ph.D. had their high school education at Tafuna High School in American Samoa from 2001 to 2005. Andrew Pati then pursued their Bachelor of Science degree in Molecular Biology at The University of New Mexico, where they studied from 2005 to 2009. Following that, Andrew Ah Young-Chapon attended UCLA as a Ph.D. candidate in Biological Chemistry from 2009 to 2015.